These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 22728760)

  • 1. Pharmacological treatment of tic disorders and Tourette Syndrome.
    Roessner V; Schoenefeld K; Buse J; Bender S; Ehrlich S; Münchau A
    Neuropharmacology; 2013 May; 68():143-9. PubMed ID: 22728760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
    Rizzo R; Gulisano M; Calì PV; Curatolo P
    Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Investigation on the status of monotherapy for newly diagnosed tic disorders and its comorbidity in children].
    Lu Q; Cui YH; Liu ZS; Sun D; Fang F; Peng J; Zhou SZ; Wang JQ; Luo R; Jiang L; Qin J; Jiang YW; Zheng Y
    Zhonghua Er Ke Za Zhi; 2020 Nov; 58(11):887-892. PubMed ID: 33120459
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
    Erenberg G
    Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.
    Roessner V; Eichele H; Stern JS; Skov L; Rizzo R; Debes NM; Nagy P; Cavanna AE; Termine C; Ganos C; Münchau A; Szejko N; Cath D; Müller-Vahl KR; Verdellen C; Hartmann A; Rothenberger A; Hoekstra PJ; Plessen KJ
    Eur Child Adolesc Psychiatry; 2022 Mar; 31(3):425-441. PubMed ID: 34757514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs in Tourette syndrome.
    Silay YS; Jankovic J
    Expert Opin Emerg Drugs; 2005 May; 10(2):365-80. PubMed ID: 15934872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment practices in Tourette syndrome: the European perspective.
    Rickards H; Cavanna AE; Worrall R
    Eur J Paediatr Neurol; 2012 Jul; 16(4):361-4. PubMed ID: 22178398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.
    Lombroso PJ; Scahill L; King RA; Lynch KA; Chappell PB; Peterson BS; McDougle CJ; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1147-52. PubMed ID: 7559308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy of Tourette's syndrome and associated disorders.
    Cohen DJ; Riddle MA; Leckman JF
    Psychiatr Clin North Am; 1992 Mar; 15(1):109-29. PubMed ID: 1549543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopharmacotherapy of Obsessive-Compulsive Symptoms within the Framework of Tourette Syndrome.
    Rothenberger A; Roessner V
    Curr Neuropharmacol; 2019; 17(8):703-709. PubMed ID: 30152283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tic syndrome].
    Czapliński A; Steck AJ; Fuhr P
    Neurol Neurochir Pol; 2002; 36(3):493-504. PubMed ID: 12185806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome.
    Gaffney GR; Perry PJ; Lund BC; Bever-Stille KA; Arndt S; Kuperman S
    J Am Acad Child Adolesc Psychiatry; 2002 Mar; 41(3):330-6. PubMed ID: 11886028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.
    Spencer TJ; Sallee FR; Gilbert DL; Dunn DW; McCracken JT; Coffey BJ; Budman CL; Ricardi RK; Leonard HL; Allen AJ; Milton DR; Feldman PD; Kelsey DK; Geller DA; Linder SL; Lewis DW; Winner PK; Kurlan RM; Mintz M
    J Atten Disord; 2008 Jan; 11(4):470-81. PubMed ID: 17934184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tourette syndrome: an analysis of its comorbidity and specific treatment].
    Castellanos FX; Acosta MT
    Rev Neurol; 2004 Feb; 38 Suppl 1():S124-30. PubMed ID: 15011166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of comorbid attention deficit hyperactivity disorder in Tourette syndrome.
    Rizzo R; Gulisano M
    Int Rev Neurobiol; 2013; 112():415-44. PubMed ID: 24295629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
    Jaworowski S; Benarroch F; Gross-Tsur V
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for tics in adult patients with Tourette syndrome and other tic disorders.
    Badenoch J; Cavanna AE
    Neurol Sci; 2020 Jul; 41(7):1923-1926. PubMed ID: 32170503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of children and adolescents with tics and Tourette syndrome.
    Gilbert D
    J Child Neurol; 2006 Aug; 21(8):690-700. PubMed ID: 16970870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.